digital health startups weight loss glp-1 Beyond the Hype: Where and how Founders Should Build in the Market GLP-1 Weight-Loss Drugs Ride Health,
Description
Shortages of the semaglutide-based injectable diabetes medication Ozempic, which accounts for 40% of GLP-1R agonist US market share, have even emerged, driven by overwhelming demand for the weight loss formulation Wegovy , both for treatment of obesity and for short-term weight loss popularized by celebrities on social media

Holst et al ., 1987

liraglutide) have been developed 21,22,23,31,32,33,34,35

Its Phase 2 weight loss data (24.2% at 48 weeks) and mechanistic advantages in hepatic fat reduction through glucagon receptor activation suggest it could surpass semaglutide's efficacy if Phase 3 results confirm the Phase 2 findings

For orthostatic assessment, measure blood pressure after lying for 5 minutes, then again at 1 and 3 minutes after standing
Food and Drug Administration and request approval for orforglipron as a treatment for obesity by the end of 2025